A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

BACKGROUND: The advent of immune checkpoint inhibitors (ICIs) has considerably expanded the armamentarium against non-small cell lung cancer (NSCLC) contributing to reshaping treatment paradigms in the advanced disease setting. While promising tissue- and plasma-based biomarkers are under investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Botticelli, Andrea, Salati, Massimiliano, Di Pietro, Francesca Romana, Strigari, Lidia, Cerbelli, Bruna, Zizzari, Ilaria Grazia, Giusti, Raffaele, Mazzotta, Marco, Mazzuca, Federica, Roberto, Michela, Vici, Patrizia, Pizzuti, Laura, Nuti, Marianna, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437908/
https://www.ncbi.nlm.nih.gov/pubmed/30917841
http://dx.doi.org/10.1186/s12967-019-1847-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437908/
https://www.ncbi.nlm.nih.gov/pubmed/30917841
http://dx.doi.org/10.1186/s12967-019-1847-x

Ejemplares similares